Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

From registration to publication; a study on Dutch academic randomized controlled trials.

Huiskens J, Kool BRJ, Bakker JM, Bruns ERJ, de Jonge SW, Olthof PB, van Rosmalen BV, van Gulik TM, Hooft L, Punt CJA.

Res Synth Methods. 2019 Oct 15. doi: 10.1002/jrsm.1379. [Epub ahead of print]

PMID:
31614063
2.

Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel.

Huiskens J, Bolhuis K, Engelbrecht MR, De Jong KP, Kazemier G, Liem MS, Verhoef C, de Wilt JH, Punt CJ, van Gulik TM; Dutch Colorectal Cancer Group.

J Am Coll Surg. 2019 Dec;229(6):523-532.e2. doi: 10.1016/j.jamcollsurg.2019.08.1445. Epub 2019 Sep 11.

PMID:
31520695
3.

Keeping track of all ongoing colorectal cancer trials using a mobile application: Usability and satisfaction results of the Dutch Colorectal Cancer Group Trials application.

Huiskens J, Gałek-Aldridge MS, Bakker JM, Olthof PB, van Gulik TM, Punt CJA, van Oijen MGH.

J Clin Transl Res. 2018 Dec 16;3(Suppl 3):435-440. eCollection 2018 Dec 17.

4.

Avoiding postoperative mortality after ALPPS-development of a tumor-specific risk score for colorectal liver metastases.

Huiskens J, Schadde E, Lang H, Malago M, Petrowsky H, de Santibañes E, Oldhafer K, van Gulik TM, Olthof PB.

HPB (Oxford). 2019 Jul;21(7):898-905. doi: 10.1016/j.hpb.2018.11.010. Epub 2019 Jan 2.

PMID:
30611560
5.

Pseudoprogression on bevacizumab treatment: tumor-dynamics in the modern era of systemic treatment for metastatic colorectal cancer.

Punt CJA, Huiskens J, van Gulik T, Engelbrecht M.

Acta Oncol. 2018 May;57(5):681-682. doi: 10.1080/0284186X.2017.1374556. Epub 2017 Nov 15. No abstract available.

PMID:
29140135
6.

Does portal vein embolization prior to liver resection influence the oncological outcomes - A propensity score matched comparison.

Huiskens J, Olthof PB, van der Stok EP, Bais T, van Lienden KP, Moelker A, Krumeich J, Roumen RM, Grünhagen DJ, Punt CJA, van Amerongen M, de Wilt JHW, Verhoef C, Van Gulik TM.

Eur J Surg Oncol. 2018 Jan;44(1):108-114. doi: 10.1016/j.ejso.2017.09.017. Epub 2017 Sep 20.

PMID:
29126672
7.

Direct detection of early-stage cancers using circulating tumor DNA.

Phallen J, Sausen M, Adleff V, Leal A, Hruban C, White J, Anagnostou V, Fiksel J, Cristiano S, Papp E, Speir S, Reinert T, Orntoft MW, Woodward BD, Murphy D, Parpart-Li S, Riley D, Nesselbush M, Sengamalay N, Georgiadis A, Li QK, Madsen MR, Mortensen FV, Huiskens J, Punt C, van Grieken N, Fijneman R, Meijer G, Husain H, Scharpf RB, Diaz LA Jr, Jones S, Angiuoli S, Ørntoft T, Nielsen HJ, Andersen CL, Velculescu VE.

Sci Transl Med. 2017 Aug 16;9(403). pii: eaan2415. doi: 10.1126/scitranslmed.aan2415.

8.

Compliance with evidence-based multidisciplinary guidelines on perihilar cholangiocarcinoma.

Coelen RJ, Huiskens J, Olthof PB, Roos E, Wiggers JK, Schoorlemmer A, van Delden OM, Klümpen HJ, Rauws EA, van Gulik TM.

United European Gastroenterol J. 2017 Jun;5(4):519-526. doi: 10.1177/2050640616673517. Epub 2016 Sep 30.

9.

Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: A case-matched comparison with palliative systemic therapy.

Olthof PB, Huiskens J, Wicherts DA, Huespe PE, Ardiles V, Robles-Campos R, Adam R, Linecker M, Clavien PA, Koopman M, Verhoef C, Punt CJ, van Gulik TM, de Santibanes E.

Surgery. 2017 Apr;161(4):909-919. doi: 10.1016/j.surg.2016.10.032. Epub 2016 Dec 27.

PMID:
28038862
10.

Regional and inter-hospital differences in the utilisation of liver surgery for patients with synchronous colorectal liver metastases in the Netherlands.

't Lam-Boer J, van der Stok EP, Huiskens J, Verhoeven RH, Punt CJ, Elferink MA, de Wilt JH, Verhoef C; CAIRO5/CHARISMA Group.

Eur J Cancer. 2017 Jan;71:109-116. doi: 10.1016/j.ejca.2016.10.026. Epub 2016 Dec 16.

PMID:
27988444
11.

Hepatic vascular inflow occlusion is associated with reduced disease free survival following resection of colorectal liver metastases.

Olthof PB, Huiskens J, Schulte NR, Wicherts DA, Besselink MG, Busch OR, Tanis PJ, van Gulik TM.

Eur J Surg Oncol. 2017 Jan;43(1):100-106. doi: 10.1016/j.ejso.2016.09.003. Epub 2016 Sep 17.

PMID:
27692534
12.

Postoperative peak transaminases correlate with morbidity and mortality after liver resection.

Olthof PB, Huiskens J, Schulte NR, Wicherts DA, Besselink MG, Busch OR, Heger M, van Gulik TM.

HPB (Oxford). 2016 Nov;18(11):915-921. doi: 10.1016/j.hpb.2016.07.016. Epub 2016 Sep 2.

13.

[Local approval procedures act as a brake on RCTs].

van der Stok EP, Huiskens J, Hemmes B, Grünhagen DJ, van Gulik TM, Verhoef C, Punt CJ.

Ned Tijdschr Geneeskd. 2016;160:D148. Dutch.

PMID:
27552934
14.

Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG).

Huiskens J, van Gulik TM, van Lienden KP, Engelbrecht MR, Meijer GA, van Grieken NC, Schriek J, Keijser A, Mol L, Molenaar IQ, Verhoef C, de Jong KP, Dejong KH, Kazemier G, Ruers TM, de Wilt JH, van Tinteren H, Punt CJ.

BMC Cancer. 2015 May 6;15:365. doi: 10.1186/s12885-015-1323-9.

15.

Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression.

Snoeren N, Huiskens J, Rijken AM, van Hillegersberg R, van Erkel AR, Slooter GD, Klaase JM, van den Tol PM, Ten Kate FJ, Jansen MC, van Gulik TM.

Ann Surg Oncol. 2011 Dec;18(13):3702-10. doi: 10.1245/s10434-011-1762-8. Epub 2011 May 18.

Supplemental Content

Loading ...
Support Center